Nitric oxide (NO) and reactive oxygen species (ROS) are key molecules in resistance to pathogens. Little is known about their role in pathogenesis of periapical lesions. To address this issue, we induced periapical lesions in mice lacking nitric oxide synthase (iNOS-/-) or phagocyte oxidase (PHOX-/-). iNOS-/- mice expressed higher levels of IL-1β, TNF-α, RANK, RANKL, and MCP-1 than C57BL/6 and PHOX-/-. Apical thickening of the periodontal ligament was also greater in iNOS-/- compared with other groups. Interestingly, ROS production did not interfere in periapical lesion progression, but seemed to be essential for the appearance of multinucleated TRAP-positive cells. Thus, periapical lesion progression in iNOS-/- was associated with an imbalance of pro-inflammatory cytokines (IL-1β and TNF-α), bone-resorptive modulators (RANK and RANKL), and MCP-1. We conclude that NO, but not ROS, controls progression of bone resorption in a murine experimental model of apical periodontitis.
ArmourKJArmourKEvan’t HofRJReidDMWeiXQLiewFY. (2001). Activation of the inducible nitric oxide synthase pathway contributes to inflammation-induced osteoporosis by suppressing bone formation and causing osteoblast apoptosis. Arthritis Rheum44:2790-2796.
BritoCNaviliatMTiscorniaACVuillierFGualcoGDighieroG. (1999). Peroxynitrite inhibits T lymphocyte activation and proliferation by promoting impairment of tyrosine phosphorylation and peroxynitrite-driven apoptotic death. J Immunol162:3356-3366.
4.
CuzzocreaSMazzonEDugoLGenoveseTDi PaolaRRuggeriZ. (2003). Inducible nitric oxide synthase mediates bone loss in ovariectomized mice. Endocrinology144:1098-1107.
5.
DesaiAMillerMJHuangXWarrenJS (2003). Nitric oxide modulates MCP-1 expression in endothelial cells: implications for the pathogenesis of pulmonary granulomatous vasculitis. Inflammation27:213-223.
6.
FanXRoyEZhuLMurphyTCAckert-BicknellCHartCM. (2004). Nitric oxide regulates receptor activator of nuclear factor-kappaB ligand and osteoprotegerin expression in bone marrow stromal cells. Endocrinology145:751-759.
7.
FanXRahnertJAMurphyTCNanesMSGreenfieldEMRubinJ (2006). Response to mechanical strain in an immortalized pre-osteoblast cell is dependent on ERK1/2. J.Cell Physiol207:454-460.
8.
FierroIMNascimento-DaSilvaVArrudaMAFreitasMSPlotkowskiMCCunhaFQ. (1999). Induction of NOS in rat blood PMN in vivo and in vitro: modulation by tyrosine kinase and involvement in bactericidal activity. J Leukoc Biol65:508-514.
9.
GaoYGrassiFRyanMRTerauchiMPageKYangX. (2007). IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation. J Clin Invest117:122-132.
HamaSTakeichiOSaitoIItoK (2007). Involvement of inducible nitric oxide synthase and receptor for advanced glycation end products in periapical granulomas. J Endod33:137-141.
12.
HofbauerLCHeufelderAE (2001). The role of osteoprotegerin and receptor activator of nuclear factor kappaB ligand in the pathogenesis and treatment of rheumatoid arthritis. Arthritis Rheum44:253-259.
13.
HollidayLSDeanADLinRHGreenwaldJEGluckSL (1997). Low NO concentrations inhibit osteoclast formation in mouse marrow cultures by cGMP-dependent mechanism. Am J Physiol272(3 Pt 2):F283-F291.
14.
HuangFPNiedbalaWWeiXQXuDFengGJRobinsonJH. (1998). Nitric oxide regulates Th1 cell development through the inhibition of IL-12 synthesis by macrophages. Eur J Immunol28:4062-4070.
15.
KastenTPCollin-OsdobyPPatelNOsdobyPKrukowskiMMiskoTP. (1994). Potentiation of osteoclast bone-resorption activity by inhibition of nitric oxide synthase. Proc Natl Acad Sci USA91:3569-3573.
16.
KawashimaNSuzukiNYangGOhiCOkuharaSNakano-KawanishiH. (2007). Kinetics of RANKL, RANK and OPG expressions in experimentally induced rat periapical lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod103:707-711.
17.
KohJ-MLeeY-SKimDJKimH-HParkJ-Y. (2006). Homocysteine enhances bone resorption by stimulation of osteoclast formation and activity through increased intracellular ROS generation. J Bone Miner Res21:1003-1011.
18.
KongYYYoshidaHSarosiITanHLTimmsECapparelliC. (1999). OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature397:315-323.
19.
LanderHM (1997). An essential role for free radicals and derived species in signal transduction. FASEB J11:118-124.
LeeNKChoiYGBaikJYHanSYJeongDWBaeYS. (2005). A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood106:852-859.
22.
LeeSKHuangHLeeSWKimKHKimKKKimH-M. (2004). Involvement of iNOS-dependent NO production in the stimulation of osteoclast survival by TNF-alpha. Exp Cell Res298:359-368.
23.
LeonardNBishopAEPolakJMTalbotIC (1998). Expression of nitric oxide synthase in inflammatory bowel disease is not affected by corticosteroid treatment. J Clin Pathol51:750-753.
24.
LiXQinLBergenstockMBevelockLMNovackDVPartridgeNC (2007). Parathyroid hormone stimulates osteoblastic expression of MCP-1 to recruit and increase the fusion of pre/osteoclasts. J Biol Chem282:33098-33106.
25.
LinS-KKokS-HLinL-DWangC-CKuoMYLinC-T. (2007). Nitric oxide promotes the progression of periapical lesion via inducing macrophage and osteoblast apoptosis. Oral Microbiol Immunol22:24-29.
RahnertJFanXCaseNMurphyTCGrassiFSenB. (2008). The role of nitric oxide in the mechanical repression of RANKL in bone stromal cells. Bone43:48-54.
28.
RalstonSHGrabowskiPS (1996). Mechanisms of cytokine induced bone resorption: role of nitric oxide, cyclic guanosine monophosphate, and prostaglandins. Bone19:29-33.
RubinJRubinCJacobsCR (2006). Molecular pathways mediating mechanical signaling in bone. Gene367:1-16.
31.
SasakiHYamamotoHTominagaKMasudaKKawaiTTeshima-KondoS. (2009a). Receptor activator of nuclear factor-kappaB ligand-induced mouse osteoclast differentiation is associated with switching between NADPH oxidase homologues. Free Radic Biol Med47:189-199.
32.
SasakiHYamamotoHTominagaKMasudaKKawaiTTeshima-KondoS. (2009b). NADPH oxidase-derived reactive oxygen species are essential for differentiation of a mouse macrophage cell line (RAW264.7) into osteoclasts. J Med Invest56:33-41.
33.
SchletterJHeineHUlmerAJRietschelET (1995). Molecular mechanisms of endotoxin activity. Arch Microbiol164:383-389.
34.
SchmittgenTDLivakKJ (2008). Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc3:1101-1108.
35.
SilvaMJVieiraLQSobrinhoAP (2008). The effects of mineral trioxide aggregates on cytokine production by mouse pulp tissue. Oral Surg Oral Med Oral Pathol Oral Radiol Endod105:e70-e76.
36.
TakeichiOSaitoIOkamotoYTsurumachiTSaitoT (1998). Cytokine regulation on the synthesis of nitric oxide in vivo by chronically infected human polymorphonuclear leucocytes. Immunology93:275-280.
37.
VernalRDezeregaADutzanNChaparroALeónRChandíaS. (2006). RANKL in human periapical granuloma: possible involvement in periapical bone destruction. Oral Dis12:283-289.
38.
XieQWChoHJCalaycayJMumfordRASwiderekKMLeeTD. (1992). Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science256:225-228.
39.
YangSRiesWLKeyLL (1998). Nicotinamide adenine dinucleotide phosphate oxidase in the formation of superoxide in osteoclasts. Calcif Tissue Int63:346-350.
40.
ZhengHYuXCollin-OsdobyPOsdobyP (2006). RANKL stimulates inducible nitric-oxide synthase expression and nitric oxide production in developing osteoclasts. An autocrine negative feedback mechanism triggered by RANKL-induced interferon-beta via NF-kappaB that restrains osteoclastogenesis and bone resorption. J Biol Chem281:15809-15820.
